GlobalData on MSN1mon
Can-Fite BioPharma secures US patent for NamodenosonSet to be issued in February 2025, the patent will expire in 2042 and covers the oral administration of the drug to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback